<?xml version="1.0" encoding="UTF-8"?>
<ref id="b63-viruses-03-00520">
 <label>63.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Butticaz</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Michielin</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Wyniger</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Telenti</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Rothenberger</surname>
    <given-names>S</given-names>
   </name>
  </person-group>
  <article-title>Silencing of both beta-trcp1 and hos (beta-trcp2) is required to suppress human immunodeficiency virus type 1 vpu-mediated cd4 down-modulation</article-title>
  <source>J Virol</source>
  <year>2007</year>
  <volume>81</volume>
  <fpage>1502</fpage>
  <lpage>1505</lpage>
  <pub-id pub-id-type="pmid">17121803</pub-id>
 </element-citation>
</ref>
